Merck (NYSE:MRK) entered into a non-exclusive license and option agreement with Cyprumed GmbH, aiming to enhance its peptide offerings through innovative oral delivery technology. Despite this ...

We recently published a list of 10 Best Pharma Stocks to Buy for Long Term Growth. In this article, we are going to take a ...

Sotatercept-csrk reduced the risk of major morbidity and mortality events in adults with WHO Group 1 PAH FC 3 or 4 at high risk of mortality.

Merck (NYSE:MRK) recently experienced a significant corporate governance event when multiple shareholder proposals were announced, with the company recommending against them for the upcoming annual ...

We recently published a list of 10 Best Medical Stocks to Buy According to Billionaires. In this article, we are going to ...

Winrevair (sotatercept ... The company – known as Merck & Co in the US and Canada – acquired sotatercept as part of its $11.5 billion takeover of Acceleron Pharma in 2021, a deal which ...

But AstraZeneca stock fell in line with pharma stocks. Merck (NYSE:MRK) recently presented promising results from the Phase 3 ZENITH trial for its drug WINREVAIR, but the company's stock performance ...

Winrevair is thought to work by blocking abnormal ... a partial reversal of the disease process in PAH. MSD – known as Merck & Co in the US and Canada – has predicted sales of the drug could ...

Merck is holding strong among billionaire favorites, despite the broader healthcare sector dodging investor affection like a ...